The stability of blood Eosinophils in chronic obstructive pulmonary disease
Open Access
- 10 January 2020
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 21 (1) , 1-4
Abstract
Blood eosinophils are a predictive biomarker of inhaled corticosteroid response in chronic obstructive pulmonary disease (COPD). We investigated blood eosinophil stability over 1 year using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 thresholds of < 100, 100- < 300 and ≥ 300 eosinophils/μL in 225 patients from the COPDMAP cohort. Blood eosinophils showed good stability (rho: 0.71, p < 0.001, ICC 0.84), and 69.3% of patients remained in the same eosinophil category at 1 year. 85.3% of patients with eosinophils < 100 cells/μL had stable counts. The majority of blood eosinophil counts remain stable over 1 year using the GOLD 2019 thresholds.Keywords
Funding Information
- Manchester Biomedical Research Centre
This publication has 13 references indexed in Scilit:
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPDNew England Journal of Medicine, 2018
- Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trialsThe Lancet Respiratory Medicine, 2018
- Eosinophils from Physiology to Disease: A Comprehensive ReviewBioMed Research International, 2018
- Eosinophils in COPD: just another biomarker?The Lancet Respiratory Medicine, 2017
- Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research DatalinkCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2017
- Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline CountsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Blood and sputum eosinophils in COPD; relationship with bacterial loadRespiratory Research, 2017
- Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Eosinophilic inflammation in COPD: prevalence and clinical characteristicsEuropean Respiratory Journal, 2014
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986